News

The VDRC is with 27.000 RNAi lines of Drosophila melanogaster, which cover 91 % of the whole genome, the largest center providing RNAi lines…

16 Jul'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

14 Jul'19

Phase 1/2 trial to be HOOKIPA’s first clinical trial in immuno-oncology

12 Jul'19

Mitosis is the process by which the genetic information encoded on chromosomes is equally distributed to two daughter cells, a fundamental feature of…

11 Jul'19

An international team led by Jijie Chai and Cyril Zipfel that included PhD Student Katarzyna Parys and Youssef Belkhadir from the GMI identified a…

10 Jul'19

Together with Corinna Dawid from the Technical University of Munich, Youssef received this award for their work on how plants use essential fatty…

04 Jul'19

The patent strengthens the unique position of ARESdb, Ares Genetics’ knowledge base of antimicrobial resistance genetics.

03 Jul'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet medical…

02 Jul'19

Upon infection cells manage to quickly switch from normal operation to immune reaction in a matter of minutes. This innate immunity requires a…

02 Jul'19

IP Protection for Scarletred®Vision in the EU, USA, Japan and Australia.

02 Jul'19

Annual general meeting on June 27, 2019 resolved on the delisting of Valneva’s ordinary shares from the Vienna Stock Exchange
Delisting shall be…

01 Jul'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

Vienna Drosophila Resource Center provides unique services helping to investigate genes' function

Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan

HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers

Centrioles - critical players in cell division

A Novel Mechanism for the Perception of Plant Peptide Hormones

GMI Group Leader Youssef Belkhadir received the Science Award Weihenstephan of the City of Freising

Ares Genetics is granted key European patent on genetic resistance testing

Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9th

How cells quickly activate innate immunity

SCARLETRED: Patents granted in Japan and Australia

Valneva Submits Delisting Application to the Vienna Stock Exchange

Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15